Sign in

CIK 0001607678 · Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461073877
Phone
858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 144 Insider Sale of Securities
  6. SC 13G Stake Amended Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. S-3ASR Offering Registration Statement
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 8-K Event Shareholder vote results
  13. 4 Open-market sale Director sold 40,000 shares at $25.00 ($1,000,000)
  14. 4 Open-market sale Director sold 16,000 shares at $24.00 ($384,000)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 8-K Event Bylaws or fiscal year change
  18. 4 Open-market sale President & CEO sold 45,000 shares at $22.45 ($1,010,250)
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 11 of 33 · 652 filings